Dr. Zakai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
S Prospect St
# 89
Burlington, VT 05405Phone+1 802-847-5971Fax+1 802-847-5946
Education & Training
- Roger Williams Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
- University of Vermont Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of Virginia School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2021 - 2026
- VT State Medical License 2003 - 2026
- RI State Medical License 2005 - 2007
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Hypertension Severity as Quantified by Hypertension Daily Dose and Blood Pressure With Risk of Stroke in REGARDS.Ying K Loo, Katherine Wilkinson, Tyler Harkness, George Howard, Virginia J Howard
Journal of the American Heart Association. 2024-09-03 - Association of Anticoagulant Choice on mortality in the Primary Treatment of Non-Cancer Venous Thromboembolism: Medicare 2011-2018.Rob F Walker, Neil A Zakai, Richard F Maclehose, Faye L Norby, Alvaro Alonso
American Journal of Epidemiology. 2024-08-09 - Factor VIII and Incident Hypertension in Black and White Adults: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.Eric Stoutenburg, Sarah Sherman, Maria Bravo, Virginia Howard, Debora Kamin Mukaz
American Journal of Hypertension. 2024-07-15
Journal Articles
- All-Cause Mortality Risk with Direct Oral Anticoagulants and Warfarin in the Primary Treatment of Venous ThromboembolismNeil A Zakai, Terrence J Adam, Thrombosis and Haemostasis
- Mechanisms and Mitigating Factors for Venous Thromboembolism in Chronic Kidney Disease: The REGARDS StudyM Cushman, N A Zakai, G Howard, Journal of Thrombosis and Haemostasis
- Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS)Monika M Safford, Mary Cushman, Brett Kissela, Neil A Zakai, Thrombosis and Haemostasis
Abstracts/Posters
- Post Discharge Risk of Venous Thromboembolism in a Primary Care PopulationNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the ChildrenÍs Hospital-Acquired Thrombosis (CHAT) ConsortiumNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The ChildrenÍs Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine LearningNeil A. Zakai, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
- Diagnosis and Follow‐up of Thrombotic Thrombocytopenic Purpura with an Automated Chemiluminescent ADAMTS13 Activity ImmunoassayDecember 15th, 2020
- Tapering Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia: Expert Consensus Based on the RAND/UCLA Modified Delphi Panel MethodDecember 8th, 2020
- Racial Differences in Protein S Tokushima and Two Protein C Variants as Genetic Risk Factors for Venous ThromboembolismOctober 20th, 2020
- Join now to see all
Professional Memberships
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: